Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. 1995

P B Challoner, and K T Smith, and J D Parker, and D L MacLeod, and S N Coulter, and T M Rose, and E R Schultz, and J L Bennett, and R L Garber, and M Chang
PathoGenesis Corporation, Seattle, WA 98119, USA.

Representational difference analysis was used to search for pathogens in multiple sclerosis brains. We detected a 341-nucleotide fragment that was 99.4% identical to the major DNA binding protein gene of human herpesvirus 6 (HHV-6). Examination of 86 brain specimens by PCR demonstrated that HHV-6 was present in > 70% of MS cases and controls and is thus a commensal virus of the human brain. By DNA sequencing, 36/37 viruses from MS cases and controls were typed as HHV-6 variant B group 2. Other herpesviruses, retroviruses, and measles virus were detected infrequently or not at all. HHV-6 expression was examined by immunocytochemistry with monoclonal antibodies against HHV-6 virion protein 101K and DNA binding protein p41. Nuclear staining of oligodendrocytes was observed in MS cases but not in controls, and in MS cases it was observed around plaques more frequently than in uninvolved white matter. MS cases showed prominent cytoplasmic staining of neurons in gray matter adjacent to plaques, although neurons expressing HHV-6 were also found in certain controls. Since destruction of oligodendrocytes is a hallmark of MS, these studies suggest an association of HHV-6 with the etiology or pathogenesis of MS.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D009836 Oligodendroglia A class of large neuroglial (macroglial) cells in the central nervous system. Oligodendroglia may be called interfascicular, perivascular, or perineuronal (not the same as SATELLITE CELLS, PERINEURONAL of GANGLIA) according to their location. They form the insulating MYELIN SHEATH of axons in the central nervous system. Interfascicular Oligodendroglia,Oligodendrocytes,Perineuronal Oligodendroglia,Perineuronal Satellite Oligodendroglia Cells,Perivascular Oligodendroglia,Satellite Cells, Perineuronal, Oligodendroglia,Perineuronal Satellite Oligodendrocytes,Interfascicular Oligodendroglias,Oligodendrocyte,Oligodendrocyte, Perineuronal Satellite,Oligodendrocytes, Perineuronal Satellite,Oligodendroglia, Interfascicular,Oligodendroglia, Perineuronal,Oligodendroglia, Perivascular,Perineuronal Satellite Oligodendrocyte,Satellite Oligodendrocyte, Perineuronal,Satellite Oligodendrocytes, Perineuronal
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D006566 Herpesviridae Infections Virus diseases caused by the HERPESVIRIDAE. Herpesvirus Infections,B Virus Infection,Infections, Herpesviridae,Infections, Herpesvirus,B Virus Infections,Herpesviridae Infection,Herpesvirus Infection,Infection, B Virus,Infection, Herpesviridae,Infection, Herpesvirus,Infections, B Virus
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000956 Antigens, Viral Substances elaborated by viruses that have antigenic activity. Viral Antigen,Viral Antigens,Antigen, Viral
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA

Related Publications

P B Challoner, and K T Smith, and J D Parker, and D L MacLeod, and S N Coulter, and T M Rose, and E R Schultz, and J L Bennett, and R L Garber, and M Chang
January 2005, Anales de la Real Academia Nacional de Medicina,
P B Challoner, and K T Smith, and J D Parker, and D L MacLeod, and S N Coulter, and T M Rose, and E R Schultz, and J L Bennett, and R L Garber, and M Chang
June 2002, Infection,
P B Challoner, and K T Smith, and J D Parker, and D L MacLeod, and S N Coulter, and T M Rose, and E R Schultz, and J L Bennett, and R L Garber, and M Chang
June 2004, Herpes : the journal of the IHMF,
P B Challoner, and K T Smith, and J D Parker, and D L MacLeod, and S N Coulter, and T M Rose, and E R Schultz, and J L Bennett, and R L Garber, and M Chang
June 2001, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica,
P B Challoner, and K T Smith, and J D Parker, and D L MacLeod, and S N Coulter, and T M Rose, and E R Schultz, and J L Bennett, and R L Garber, and M Chang
January 2021, Frontiers in immunology,
P B Challoner, and K T Smith, and J D Parker, and D L MacLeod, and S N Coulter, and T M Rose, and E R Schultz, and J L Bennett, and R L Garber, and M Chang
May 2003, The Journal of infectious diseases,
P B Challoner, and K T Smith, and J D Parker, and D L MacLeod, and S N Coulter, and T M Rose, and E R Schultz, and J L Bennett, and R L Garber, and M Chang
June 2002, Archives of neurology,
P B Challoner, and K T Smith, and J D Parker, and D L MacLeod, and S N Coulter, and T M Rose, and E R Schultz, and J L Bennett, and R L Garber, and M Chang
December 1998, Multiple sclerosis (Houndmills, Basingstoke, England),
P B Challoner, and K T Smith, and J D Parker, and D L MacLeod, and S N Coulter, and T M Rose, and E R Schultz, and J L Bennett, and R L Garber, and M Chang
November 2010, Mayo Clinic proceedings,
P B Challoner, and K T Smith, and J D Parker, and D L MacLeod, and S N Coulter, and T M Rose, and E R Schultz, and J L Bennett, and R L Garber, and M Chang
April 2008, PloS one,
Copied contents to your clipboard!